Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEPOLIZUMAB Cause Complication associated with device? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Complication associated with device have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.0% of all adverse event reports for MEPOLIZUMAB.

8
Reports of Complication associated with device with MEPOLIZUMAB
0.0%
of all MEPOLIZUMAB reports
1
Deaths
5
Hospitalizations

How Dangerous Is Complication associated with device From MEPOLIZUMAB?

Of the 8 reports, 1 (12.5%) resulted in death, 5 (62.5%) required hospitalization.

Is Complication associated with device Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does MEPOLIZUMAB Cause?

Asthma (11,033) Dyspnoea (9,192) Wheezing (6,093) Product dose omission issue (5,873) Cough (4,577) Pneumonia (4,107) Therapeutic product effect incomplete (4,106) Drug ineffective (3,880) Loss of personal independence in daily activities (3,566) Fatigue (2,656)

What Other Drugs Cause Complication associated with device?

ETONOGESTREL (6,047) COPPER (1,083) BACLOFEN (525) TREPROSTINIL (422) EPOPROSTENOL (399) LEVONORGESTREL (344) ADALIMUMAB (269) CARBIDOPA\LEVODOPA (169) MACITENTAN (169) TEDUGLUTIDE (133)

Which MEPOLIZUMAB Alternatives Have Lower Complication associated with device Risk?

MEPOLIZUMAB vs MEPROBAMATE MEPOLIZUMAB vs MERCAPTOPURINE MEPOLIZUMAB vs MEROPENEM MEPOLIZUMAB vs MEROPENEM ANHYDROUS MEPOLIZUMAB vs MESALAMINE

Related Pages

MEPOLIZUMAB Full Profile All Complication associated with device Reports All Drugs Causing Complication associated with device MEPOLIZUMAB Demographics